# Alterity Therapeutics Ltd: Form 20-F for the period ended Jun 30, 2022

- Company: [Alterity Therapeutics Ltd](/companies/athe.md) (CIK 1131343)
- Form: 20-F
- Filed: 2022-08-31
- Accepted by EDGAR: Aug 31, 2022, 12:24 ET
- Period: 2022-06-30
- Accession: 0001213900-22-052529
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1131343/000121390022052529/f20f2022_alteritytherap.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1131343/000121390022052529/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Income tax | 12 months, 2021-07-01 to 2022-06-30 | AUD 70.0k | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2021-07-01 to 2022-06-30 | AUD 12.8m | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2021-07-01 to 2022-06-30 | −AUD 0.53 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2021-07-01 to 2022-06-30 | −AUD 0.53 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2021-07-01 to 2022-06-30 | −AUD 12.3m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2021-07-01 to 2022-06-30 | AUD 89.1k | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2022-06-30 | AUD 34.8m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2022-06-30 | AUD 41.1m | ifrs-full:CurrentAssets |
| Total assets | at 2022-06-30 | AUD 41.4m | ifrs-full:Assets |
| Current liabilities | at 2022-06-30 | AUD 5.8m | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2022-06-30 | AUD 5.9m | ifrs-full:Liabilities |
| Shareholders' equity | at 2022-06-30 | AUD 35.5m | ifrs-full:Equity |
| Shares outstanding | at 2022-06-30 | 2,406,874,578 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1131343/000121390022052529/f20f2022_alteritytherap.htm

Filed Aug 31, 2022.
Source: SEC EDGAR, the filing index for accession 0001213900-22-052529. Last ingested by Listed: Oct 30, 2026, 06:15 ET. No prices; not investment advice.